Colfax Corp. (CFX) Tops Q1 EPS by 4c, Revenues Beat; Raises FY21 EPS Guidance, Provides 2Q EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Colfax Announces First Quarter 2021 Results
April 29, 2021 6:00 AM EDTReported $0.19 EPS from continuing operations and achieved $0.44 of adjusted EPSGrew sales 8% including organic sales-per-day growth of 9%Recently announced expanded fast-growing foot & ankle business with April acquisition of MedShapeRaising low-end of adjusted 2021 EPS guidance range to $2.05-$2.15
ANNAPOLIS JUNCTION, MD, April 29, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its... More
